Cambridge, MA · Founded 2017 · Privately Held (backing)
Developer of a cell engineering platform designed to offer healthy and functional cells. Kytopen is based in Cambridge, MA and was founded in 2017. Its last reported valuation was $47 million in Sep 2024. It has raised $52.9 million across 5 recorded rounds; the latest was a $7.1 million early-stage round in Feb 2025.
Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$52.9M
Last round
Early Stage VC
Feb 2025
Cap table — not yet on record
Kytopen's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kytopen with a free account
·The complete investor list: 16 names
·Watch Kytopen: the Monday email on marks, rounds and moves